News|Articles|March 3, 2005

Nanoparticle Synthesis Process Facilitates Chiral Separations

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content

Women in STEM: Early Phase Drug Development

BySusan Haigney

February 6th 2026

Male red plastic toy businessman silhouette | Image Source: ©H_Ko -stock.adobe.com

Rare Disease Treatments: Navigating the Economics of Global Innovation

ByNathan Edwards, PhD

February 5th 2026

Women in STEM: Cultivating Scientific Confidence

BySusan Haigney

February 4th 2026

Shaping the Future of Microbial Development: From Gene to GMP

ByFUJIFILM Biotechnologies

February 4th 2026

FDA Approves New Breast Cancer Treatment | Created with Canva

FDA Grants Priority Review to AZ's Datroway for Metastatic Triple Negative Breast Cancer

ByZachary Zubulake

February 3rd 2026

Nanoparticle Synthesis Process Facilitates Chiral Separations

Newsletter

Related Content

Women in STEM: Early Phase Drug Development

Rare Disease Treatments: Navigating the Economics of Global Innovation

Women in STEM: Cultivating Scientific Confidence

Shaping the Future of Microbial Development: From Gene to GMP

FDA Grants Priority Review to AZ's Datroway for Metastatic Triple Negative Breast Cancer

Trending on Pharmaceutical Technology

Rare Disease Treatments: Navigating the Economics of Global Innovation

Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up

Women in STEM: Early Phase Drug Development

PharmTech Weekly Roundup - February 6, 2026

FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B